Table 2.

The inhibitory potentials of the investigated 8 and 14 targets towards EGFR (Wild) and EGFR (T790M).

Compound	EGFR IC50 (µM)
	Wild	T790M
8	0.131 ± 0.008	0.027 ± 0.002
14	0.203 ± 0.012	0.156 ± 0.009
Erlotinib	0.042 ± 0.003	0.009 ± 0.001